Ï㽶ÊÓƵ

Jonathan Spicer

Academic title(s): 
  • Assistant Professor; 
  • Program Director, Advanced Thoracic and Upper GI Surgical Oncology Fellowship
Jonathan Spicer
Contact Information
Email address: 
jonathan.spicer [at] mcgill.ca
Phone: 
(514) 934-1934 Ext 43050
Location: 
Montreal General Hospital
Ï㽶ÊÓƵ Health Centre (MUHC - Glen) - Royal Victoria Hospital
Office: 
L8-520
Division: 
Thoracic Surgery
Hospital title: 
Medical Director, McGill Thoracic Oncology Network
Degree(s): 

MD, PhD, FRCSC

Current research: 
  • Periadjuvant therapy for operable lung cancer
  • Translational lung cancer research
  • Cancer immunology
  • Clinical trials
Clinical Interests: 
  • Extended resections for thoracic cancers
  • Minimally invasive thoracic surgery
  • Tracheal surgery
  • Chest wall surgery
Language(s) spoken: 
English
French
Biography: 

Dr. Jonathan Spicer is an associate professor of surgery at Ï㽶ÊÓƵ, where he is the medical director of the Ï㽶ÊÓƵ Health Center (MUHC) Thoracic Oncology Network. He chairs the McGill regional thoracic oncology tumor board and is co-director of the MUHC thoracic oncology clinical trials unit. Dr. Spicer is a surgeon scientist leading a broad research program covering basic, translational and clinical research topics. He trained in general surgery at Ï㽶ÊÓƵ and subsequently in cardiothoracic surgery at the University of Texas, MD Anderson Cancer Centre. On a basic science front, Dr. Spicer is recognized as a leader in our understanding of how neutrophils impact cancer progression, and in particular, on the role of neutrophil extracellular traps in cancer biology. On a clinical front, Dr. Spicer has developed one of the most active research programs in the area of neoadjuvant immunotherapy for operable lung cancer. He is an expert in surgical enhanced recovery protocols and his clinical practice is focused on minimal access techniques for pulmonary surgery and extended resections for thoracic malignancies. He is the program director for the McGill Advanced Thoracic and Upper GI Surgical Oncology Fellowship. Dr. Spicer is the research chair for the Canadian Association of Thoracic Surgeons, director of the Canadian Cancer Trials Mesothelioma Working Group and sits on numerous steering committees for phase 2 and 3 international trials investigating the use of novel therapies prior to lung cancer resections.

Selected publications: 

Follow us on:

Back to top